. Author manuscript; available in PMC: 2011 Nov 1.

Published in final edited form as: Am J Obstet Gynecol. 2010 Aug 21;203(5):512.e1–512.e6. doi: 10.1016/j.ajog.2010.06.071

Table 4. Change in Support Loss Measures 2 years after surgery in the CARE Trial.

	Baseline N=322	24 Month N=250	Change from Baseline N=250	SRM	Correlation of change from baseline and change in POPDI (r)	Correlation with change from baseline and change in POPIQ (r)

SL5
Mean (SD)	27.4 (11.3)	4.4 (3.3)	-22.7 (10.8)^*	2.10	0.24^*	0.10
Range	7 to 60	0 to 15	-53 to 0	2.10	0.24^*	0.10

SL3
Mean (SD)	20.6 (9.7)	2.6 (2.0)	-17.6 (9.3)	1.89	0.20^*	0.09
Range	4 to 48	0 to 11	-42 to 0	1.89	0.20^*	0.09

SLmax
Mean (SD)	3.9 (2.4)	-1.5 (1.2)	-5.4 (2.4)^*	2.25	0.22^*	0.08
Range	-1 to 12	-3 to 3	-13 to 0	2.25	0.22^*	0.08

POPQ Stage
Mean (SD)	3.0 (0.6)	1.3 (0.8)	-1.8 (0.9)^*	2.00	0.17^*	0.01
Range	2 to 4	0 to 3	-4 to 0	2.00	0.17^*	0.01

p<0.01

POPDI, Pelvic Organ Prolapse Distress Inventory; POPIQ, Pelvic Organ Prolapse Impact Questionnaire

SRM, standardized response mean; values greater than 1 indicate excellent responsiveness.